Epigral has achieved a major milestone by commissioning India’s first Chlorotoluenes Value Chain Facility at its Dahej Complex in Gujarat on March 24, 2025. This cutting-edge facility enhances Epigral’s integrated manufacturing capabilities, reinforcing its leadership in the specialty chemicals sector.
The new facility will produce high-quality chlorotoluene-based intermediates, essential for the pharmaceutical and agrochemical industries. This development aligns with India’s growing focus on self-reliance in chemical manufacturing, reducing dependency on imports and boosting domestic supply chains.
In the exchange filing, Epigral shared, “The company has successfully commissioned India’s first Chlorotoluenes Value Chain Facility at its Dahej Complex in Gujarat on 24th March, 2025. This facility will further strengthen Epigral’s integrated complex and will supply intermediates for pharmaceutical and agrochemical industries.”
Epigral’s investment in this state-of-the-art facility underscores its commitment to innovation, sustainability, and industry growth.
